BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 24533168)

  • 21. Neurogenic pulmonary edema caused by spontaneous cerebellar hemorrhage: A fatal case report.
    Dai Q; Su L
    Surg Neurol Int; 2014; 5():103. PubMed ID: 25101198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence, in-hospital mortality, and factors related to neurogenic pulmonary edema after spontaneous subarachnoid hemorrhage: a systematic review and meta-analysis.
    Guo L; Yang X; Yang B; Tang G; Li C
    Neurosurg Rev; 2023 Jul; 46(1):169. PubMed ID: 37432487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transpulmonary Thermodilution-Based Management of Neurogenic Pulmonary Edema After Subarachnoid Hemorrhage.
    Mutoh T; Kazumata K; Ueyama-Mutoh T; Taki Y; Ishikawa T
    Am J Med Sci; 2015 Nov; 350(5):415-9. PubMed ID: 26517502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of P2X purinoceptor 7 in neurogenic pulmonary edema after subarachnoid hemorrhage in rats.
    Chen S; Zhu Z; Klebe D; Bian H; Krafft PR; Tang J; Zhang J; Zhang JH
    PLoS One; 2014; 9(2):e89042. PubMed ID: 24533168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Melatonin attenuates neurogenic pulmonary edema via the regulation of inflammation and apoptosis after subarachnoid hemorrhage in rats.
    Chen J; Qian C; Duan H; Cao S; Yu X; Li J; Gu C; Yan F; Wang L; Chen G
    J Pineal Res; 2015 Nov; 59(4):469-77. PubMed ID: 26383078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabinoid Receptor Type 2 Agonist Attenuates Acute Neurogenic Pulmonary Edema by Preventing Neutrophil Migration after Subarachnoid Hemorrhage in Rats.
    Fujii M; Sherchan P; Soejima Y; Doycheva D; Zhao D; Zhang JH
    Acta Neurochir Suppl; 2016; 121():135-9. PubMed ID: 26463937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of S100A9 alleviates neurogenic pulmonary edema after subarachnoid hemorrhage.
    Wang G; Hou G; Tian Q; Liu C; Guo Y; Wei H; Zhang Z; Li M
    Biochem Pharmacol; 2023 Dec; 218():115905. PubMed ID: 37949322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current management of delayed cerebral ischemia: update from results of recent clinical trials.
    Brathwaite S; Macdonald RL
    Transl Stroke Res; 2014 Apr; 5(2):207-26. PubMed ID: 24338266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Endovascular Perforation Model of Subarachnoid Haemorrhage in Rat Produces Heterogeneous Infarcts that Increase with Blood Load.
    Greenhalgh AD; Rothwell NJ; Allan SM
    Transl Stroke Res; 2012 Mar; 3(1):164-72. PubMed ID: 24323760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controversies and evolving new mechanisms in subarachnoid hemorrhage.
    Chen S; Feng H; Sherchan P; Klebe D; Zhao G; Sun X; Zhang J; Tang J; Zhang JH
    Prog Neurobiol; 2014 Apr; 115():64-91. PubMed ID: 24076160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. P2X7 receptor antagonism inhibits p38 mitogen-activated protein kinase activation and ameliorates neuronal apoptosis after subarachnoid hemorrhage in rats.
    Chen S; Ma Q; Krafft PR; Chen Y; Tang J; Zhang J; Zhang JH
    Crit Care Med; 2013 Dec; 41(12):e466-74. PubMed ID: 23963136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. P2X7R/cryopyrin inflammasome axis inhibition reduces neuroinflammation after SAH.
    Chen S; Ma Q; Krafft PR; Hu Q; Rolland W; Sherchan P; Zhang J; Tang J; Zhang JH
    Neurobiol Dis; 2013 Oct; 58():296-307. PubMed ID: 23816751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The second transmembrane domain of P2X7 contributes to dilated pore formation.
    Sun C; Heid ME; Keyel PA; Salter RD
    PLoS One; 2013; 8(4):e61886. PubMed ID: 23613968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of montreal cognitive assessment and mini-mental state examination in evaluating cognitive domain deficit following aneurysmal subarachnoid haemorrhage.
    Wong GK; Lam SW; Wong A; Ngai K; Poon WS; Mok V
    PLoS One; 2013; 8(4):e59946. PubMed ID: 23573223
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.